Sign up for Biomarker Discovery in Prostate Cancer with Metabolomics Webinar on July 14

News & Events

News

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program

November 1. 2023

Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio has joined its COE Program. Panome Bio is a metabolomics and proteomics services company that provides biopharma innovators unparalleled access to the biomolecules closest to phenotype using its proprietary Next Generation Metabolomics™ technology.

Skip to content